Your browser doesn't support javascript.
loading
The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19.
de Ligt, Marlies; Hesselink, Matthijs K C; Jorgensen, Johanna; Jocken, Johan W E; Blaak, Ellen E; Goossens, Gijs H.
Afiliación
  • de Ligt M; Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Hesselink MKC; Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Jorgensen J; Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Jocken JWE; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Blaak EE; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Goossens GH; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
Obesity (Silver Spring) ; 29(9): 1423-1426, 2021 09.
Article en En | MEDLINE | ID: mdl-33955183

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Valsartán / Enzima Convertidora de Angiotensina 2 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Obesity (Silver Spring) Asunto de la revista: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Valsartán / Enzima Convertidora de Angiotensina 2 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Obesity (Silver Spring) Asunto de la revista: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos